TO INNOVATIONS

SATURDAY 29 OCTOBER 2016 POSTER DISCUSSION SESSIONS
[PD-1008-29]
Improving detection of tuberculosis through active case finding among children attending informal schools in urban informal settlements
in Nairobi
E Mueni, R Wangusi, E Omanya, F Leli, B Sialaal, D Wanyama, E Koech, D Nyukuri (Kenya)
[PD-1009-29]
Evaluation of the Xpert® MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea
S Kasa Tom, H Welch, C Kilalang, N Tefuarani, E Lavu, K Johnson, R Magaye, T Duke (Papua New Guinea, United States of America, Austria)
[PD-1010-29]
Increasing childhood TB notification through systematic screening in public-sector hospitals in rural Pakistan: an update
A Malik, F Amanullah, M Jaswal, S Siddiqui, J Ahmed, S Saleem, A Khurshid, H Hussain (Pakistan, United States of America)
[PD-1011-29]
Reaching missing paediatric TB cases through contact tracing: experience from sixty districts in India
S Waikar, A Pathak, P Singh, S Upadhaya, P Jha, R Kumar, N Sinha, A Das (India)
[PD-1012-29]
Targeting missed opportunities for childhood TB management integration in Nigeria using comprehensive OVC programmes:
PEPFAR/USAID/FHI360 experience
T Idaboh, H Khamofu, C Gana, S Olarewaju, M Odo, I Ezekpeazu, C Agbakwuru, R Mamudu, K Torpey (Nigeria)
[PD-1013-29]
Tolerability of the string test for tuberculosis diagnosis in children aged 4-14 years
K T Tafur, M J Mendoza, C Pinedo, S R Leon, J M Coit, C C Contreras, R I Calderon, M F Franke (Peru, United States of America)
POSTER DISCUSSION SESSION 41 3 12:15-13:15 3 POSTER AREA HALL 2
LATENT TB INFECTION TESTING: WHO AND HOW
Chair: Robert Makombe (South Africa) – Section: Tuberculosis
[PD-1014-29]
Risk factors for active tuberculosis in human immunodeficiency virus co-infected tuberculosis contacts, Taiwan
P H Lee, Y A Lin, M J Lu, M Y Chou, S H Huang, Y F Huang (Taiwan)
[PD-1015-29]
Diagnostic specificity of immunological methods in diagnosis of the tuberculosis and latent tuberculosis infection among children
A Starshinova, N Korneva, I Dovgaluk, M Plahtienko, E Bobkevich, B Pinegin, V Murugin (Russian Federation)
[PD-1016-29]
T-SPOT performance in routine paediatric practice in a low TB burden setting
H Highsmith, A Gendreau, H L Kirchner, C Callahan, N Harris, A Mandalakas (United States of America)
[PD-1017-29]
Pregnancy-associated decreased TST vs. QFT positivity and lower QFT mitogen and Mycobacterium tuberculosis antigen responses
compared to postpartum in HIV-infected women
S LaCourse, L Cranmer, D Matemo, J Kinuthia, B Richardson, D Horne, G John-Stewart (United States of America, Kenya)
[PD-1018-29]
Latent TB in patients with chronic renal failure: results from a national survey
K Bhatt, M Dedicoat, J Baharani (United Kingdom)
[PD-1019-29]
Micronutrient supplementation augments anti-mycobacterial immune responses in TST-reactive household contacts
M J Saunders, K Zevallos, M A Tovar, R Montoya, C Santillan, M Baldwin, S Schumacher, C A Evans (United Kingdom, Peru)
[PD-1020-29]
Using country of origin to prioritise testing for latent tuberculosis infection in the United States
B J Baker, J Yeats, J S Kammerer (United States of America)
[PD-1021-29]
Knowledge and attitudes about active and latent tuberculosis among index cases and contacts in three high TB burden Brazilian capitals
A Trajman, F Salame, M D S Ferreira, J Ramos, G Salgado, A B Melo, M Cordeiro-Santos, M F Militão de Albuquerque, P Hill, R Arraes Ximenes,
D Menzies, ACT4-Brazil Study Group (Brazil, Canada, New Zealand)
[PD-1022-29]
Programmatic implementation of the interferon-gamma release assay in Norway, 2009-2014
B A Winje, A M B Kran, E Heldal (Norway)
[PD-1023-29]
Strong standard operating procedure: a key to effective implementation of isoniazid preventive therapy
A Musyani (Tanzania, United Rep.)
SATURDAY 29 OCT
26-29 OCTOBER 2016 - LIVERPOOL - UNITED KINGDOM
171